Market Overview

NetworkNewsBreaks – Merus N.V. (NASDAQ: MRUS) Secures $79.2 Million in Underwritten Public Offering

Share:

Merus N.V. (NASDAQ:MRUS), a clinical-stage bispecific antibody company developing Biclonics(R), has closed an underwritten public offering of 5,462,500 of its common shares, which includes 712,500 additional shares per the full exercise of the over-allotment option granted to the underwriters. Merus N.V. secured approximately $79.2 million in gross proceeds from the offering, with each of […]

Merus N.V. (NASDAQ:MRUS), a clinical-stage bispecific antibody company developing Biclonics(R), has closed an underwritten public offering of 5,462,500 of its common shares, which includes 712,500 additional shares per the full exercise of the over-allotment option granted to the underwriters. Merus N.V. secured approximately $79.2 million in gross proceeds from the offering, with each of the shares sold at the public offering price of $14.50. The company intends to use the proceeds to advance clinical development of its product candidates, preclinical research and technology development, as well as for working capital and other general corporate purposes. ROTH Capital Partners acted as co-manager for the offering.

To view the full press release, visit http://nnw.fm/W0hHA

About Merus N.V.

Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics(R). Biclonics, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity. For more information, please visit https://Merus.nl.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text "STOCKS" to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com